Friday, October 23, 2009

Should the FDA be sharing more about clinical trials?

According to the LA Times, the FDA could be providing more information about approved drugs with doctors and the public. While most of the information doctors use to prescribe medicine and information patients use to learn about the medicine, there's a lot of information that is left out about the drugs. The article points out a few cases in which the FDA doesn't share some of the road bumps that occurred in Phase III clinical trials, such as the drug being ineffective in some of the population.

What do you think? I think that the FDA should share all of the information they possibly can on a drug, and how the drug was accepted by different people's systems. If a drug barley passed the FDA approval, they should be required to share that too, as it could help doctors when prescribing it to individuals. Read the full article here.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment